(R) -2- (4-amidinophenylaminomethyl) -1-methyl-5- [1- (carboxymethylamino) -1- (pyrrolidinocarbonyl) - ethyl] -benzimidazole, its monohydrochloride, to processes for their preparation and use as medicaments

The present invention are the crystalline forms of the compounds (R) -2- (4-amidinophenylaminomethyl) -1-methyl-5- [1- (carboxymethylamino) -1- (Pyrrolidinocarbonyl) -ethyl] -benzimidazole and its monohydrochloride, to processes for their preparation and their use as medicaments.